Thursday, June 21, 2018

Clinical Trial for EPP! Participants are needed for participation in a Phase II clinical trial to study an investigational drug for EPP




Drug for EPP. CONTACT THE APF ON 1-866-APF-3635 or email porphyus@porphyriafoundation.org to learn
more.

An oral investigational drug has been developed with the potential to increase sunlight duration and tolerance in
individuals with EPP. This phase II clinical trial is needed to understand if the investigational drug works and to
ensure that it is safe. The study duration is 24 weeks including follow-up.

 You must be age 18-70 to participate
and have a confirmed diagnosis of EPP. All travel is included and will be arranged by a concierge service.

Contact the APF today – trial spaces will fill quickly! 1-866-APF-3635.

"Remember...Research is the key to YOUR cure!"

Each Step Toward Finding an Effective Treatment is Important!





No comments:

Post a Comment

Alie Campbell VP

ALIE CAMPBELL PORPHYRIA and ME TYPE OF PORPHYRIA Variegate Porphyria (VP) My story is probably not much different than most. I...